Chargement en cours...
Altering cancer transcriptomes using epigenomic inhibitors
BACKGROUND: Due to the hyper-activation of WNT signaling in a variety of cancer types, there has been a strong drive to develop pathway-specific inhibitors with the eventual goal of providing a chemotherapeutic antagonist of WNT signaling to cancer patients. A new category of drugs, called epigeneti...
Enregistré dans:
| Publié dans: | Epigenetics Chromatin |
|---|---|
| Auteurs principaux: | , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
BioMed Central
2015
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4506402/ https://ncbi.nlm.nih.gov/pubmed/26191083 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1756-8935-8-9 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|